BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17889725)

  • 1. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Shirwan H; Yaniv I; Askenasy N
    Exp Hematol; 2007 Oct; 35(10):1601-12. PubMed ID: 17889725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Yaniv I; Shirwan H; Askenasy N
    Stem Cells; 2007 Jun; 25(6):1448-55. PubMed ID: 17363551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors.
    Pearl-Yafe M; Stein J; Yolcu ES; Farkas DL; Shirwan H; Yaniv I; Askenasy N
    Stem Cells; 2007 Dec; 25(12):3194-203. PubMed ID: 17872500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor receptors support murine hematopoietic progenitor function in the early stages of engraftment.
    Pearl-Yafe M; Mizrahi K; Stein J; Yolcu ES; Kaplan O; Shirwan H; Yaniv I; Askenasy N
    Stem Cells; 2010 Jul; 28(7):1270-80. PubMed ID: 20506490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional changes induced in hematopoietic stem/progenitor cells after gamma-ray radiation exposure.
    Simonnet AJ; Nehmé J; Vaigot P; Barroca V; Leboulch P; Tronik-Le Roux D
    Stem Cells; 2009 Jun; 27(6):1400-9. PubMed ID: 19489102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of alpha2 integrin separates long-term and short-term reconstituting Lin-/loThy1.1(lo)c-kit+ Sca-1+ hematopoietic stem cells.
    Wagers AJ; Weissman IL
    Stem Cells; 2006 Apr; 24(4):1087-94. PubMed ID: 16373693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
    Fecho K; Bentley SA; Cohen PL
    Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftment of W/c-kit mutant mice is determined by stem cell competition, not by increased marrow 'space'.
    Fleishman RA
    Exp Hematol; 1996 Feb; 24(2):209-13. PubMed ID: 8641343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells.
    Osawa M; Nakamura K; Nishi N; Takahasi N; Tokuomoto Y; Inoue H; Nakauchi H
    J Immunol; 1996 May; 156(9):3207-14. PubMed ID: 8617942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regeneration capability of Lin-/c-Kit+/Sca-1+ cells with or without radiation exposure for repopulation of peripheral blood in lethally irradiated mice monitored using Ly5.1 isotype on days 35, 90, and 270 after transplantation.
    Otsuka K; Hirabayashi Y; Tsuboi I; Inoue T
    Exp Hematol; 2010 May; 38(5):417-25. PubMed ID: 20304046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
    Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
    Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
    Liu WH; Chang LS
    Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
    Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
    Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and p53-independent manner.
    Choi YJ; Ok DW; Kwon DN; Chung JI; Kim HC; Yeo SM; Kim T; Seo HG; Kim JH
    FEBS Lett; 2004 Sep; 575(1-3):41-51. PubMed ID: 15388331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of P-selectin and E-selectin on the differentiation of murine hematopoietic progenitor cells.
    Eto T; Winkler I; Purton LE; Lévesque JP
    Exp Hematol; 2005 Feb; 33(2):232-42. PubMed ID: 15676218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells.
    Stahnke K; Hecker S; Kohne E; Debatin KM
    Exp Hematol; 1998 Aug; 26(9):844-50. PubMed ID: 9694505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
    Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
    Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.
    Uchida N; Tsukamoto A; He D; Friera AM; Scollay R; Weissman IL
    J Clin Invest; 1998 Mar; 101(5):961-6. PubMed ID: 9486965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.